Helus Pharma Inc. (HELP) vs Starling Oncology, Inc. (STLN)

A side-by-side comparison of Helus Pharma Inc. and Starling Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Helus Pharma Inc. logo
HELP
Helus Pharma Inc.
$669M
$10.79HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Starling Oncology, Inc. logo
STLN
Starling Oncology, Inc.
$656M
$6.56HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — HELP vs STLN

growth of $100 · dividends reinvested · last 1y
HELP +89.4% (+89.4%/yr)STLN +8.6% (+8.6%/yr)HELP compounded faster over this window
100150200Start $100$189$109
HELP STLN

HELP vs STLN: by the numbers

  • •HELP is the larger company ($669M vs $656M market cap).
  • •HELP is profitable (329.09% net margin) while STLN runs a net loss (-6.18%).

Metrics side by side

Valuation

MetricHELPSTLN
P/S ratioN/A1.12
P/B ratio2.77N/A

Profitability

MetricHELPSTLN
Gross margin100.27%15.69%
Operating margin317.06%-4.44%
Net margin329.09%-6.18%
ROE-75.79%N/A
ROIC-73.27%-31.32%

Frequently asked

Is HELP or STLN more profitable?
HELP runs the higher net margin — HELP at 329.09% versus STLN at -6.18%.

Go deeper

Full HELP analysisFull STLN analysisInteractive comparison tool

Dig into the metrics

Helus Pharma ROEStarling Oncology ROEHelus Pharma operating marginStarling Oncology operating marginHelus Pharma revenue growthStarling Oncology revenue growthHelus Pharma free cash flowStarling Oncology free cash flow

Helus Pharma & Starling Oncology appear in these rankings

Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.